Kimberly Moran

Senior Vice President, Head of Rare Diseases US at UCB

Speaker

Kim Moran is the SVP & Head of U.S. Rare Diseases, where she oversees the rare disease commercial organization in the U.S., building the strategy of the U.S. Rare Disease Portfolio, with an emphasis on operations, regulatory, clinical, technology, and marketing.  She is a member of the U.S. Leadership Team and is passionate about leading strong teams with a focus on employee engagement and innovative thinking.

In 2023-2024, she led high-performing cross-functional teams toward the FDA approvals for the launches of two U.S. rare disease assets that have been identified as 2 of the 5 UCB growth drivers as the company starts its unparalleled launch cycle.